Biocatalytic Synthesis of Ribonucleoside Analogues
Author Information
Author(s): Salihovic Admir, Ascham Alex, Rosenqvist Petja S., Taladriz-Sender Andrea, Hoskisson Paul A., Hodgson David R. W., Grogan Gideon, Burley Glenn A.
Primary Institution: University of Strathclyde
Hypothesis
Can the type II nucleoside 2′-deoxyribosyltransferase from Lactobacillus leichmannii be used to prepare ribonucleoside analogues?
Conclusion
The study demonstrates that LlNDT-2 can efficiently catalyze the formation of ribonucleosides and 2′-fluoro-2′-deoxynucleosides in a one-step, environmentally friendly process.
Supporting Evidence
- The study identified that LlNDT-2 can accept both purine and pyrimidine nucleobases.
- Enzyme loading significantly increased the conversion rates of ribonucleoside synthesis.
- The process was shown to be scalable, achieving ribonucleoside production on a millimolar scale.
- Structural studies provided insights into the enzyme's substrate recognition mechanisms.
Takeaway
Scientists found a way to use a special enzyme to make important building blocks for medicines in a simpler and cleaner way.
Methodology
The study used enzymatic transglycosylation catalyzed by LlNDT-2 with various nucleoside donors to prepare ribonucleoside analogues.
Limitations
The study primarily focused on the substrate scope and did not extensively explore all possible nucleobase modifications.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website